Cargando…

Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy

Detalles Bibliográficos
Autores principales: Jeru, Isabelle, Hentgen, Véronique, Normand, Sylvain, Duquesnoy, Philippe, Cochet, Emmanuelle, Delwail, Adriana, Grateau, Gilles, Marlin, Sandrine, Amselem, Serge, Lecron, Jean-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194427/
http://dx.doi.org/10.1186/1546-0096-9-S1-O31
_version_ 1782213969870585856
author Jeru, Isabelle
Hentgen, Véronique
Normand, Sylvain
Duquesnoy, Philippe
Cochet, Emmanuelle
Delwail, Adriana
Grateau, Gilles
Marlin, Sandrine
Amselem, Serge
Lecron, Jean-Claude
author_facet Jeru, Isabelle
Hentgen, Véronique
Normand, Sylvain
Duquesnoy, Philippe
Cochet, Emmanuelle
Delwail, Adriana
Grateau, Gilles
Marlin, Sandrine
Amselem, Serge
Lecron, Jean-Claude
author_sort Jeru, Isabelle
collection PubMed
description
format Online
Article
Text
id pubmed-3194427
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31944272011-10-18 Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy Jeru, Isabelle Hentgen, Véronique Normand, Sylvain Duquesnoy, Philippe Cochet, Emmanuelle Delwail, Adriana Grateau, Gilles Marlin, Sandrine Amselem, Serge Lecron, Jean-Claude Pediatr Rheumatol Online J Oral Presentation BioMed Central 2011-09-14 /pmc/articles/PMC3194427/ http://dx.doi.org/10.1186/1546-0096-9-S1-O31 Text en Copyright ©2011 Jeru et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Jeru, Isabelle
Hentgen, Véronique
Normand, Sylvain
Duquesnoy, Philippe
Cochet, Emmanuelle
Delwail, Adriana
Grateau, Gilles
Marlin, Sandrine
Amselem, Serge
Lecron, Jean-Claude
Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
title Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
title_full Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
title_fullStr Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
title_full_unstemmed Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
title_short Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
title_sort role of il-1b in nlrp12-associated autoinflammatory disorders and resistance to anti-il-1 therapy
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194427/
http://dx.doi.org/10.1186/1546-0096-9-S1-O31
work_keys_str_mv AT jeruisabelle roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT hentgenveronique roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT normandsylvain roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT duquesnoyphilippe roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT cochetemmanuelle roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT delwailadriana roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT grateaugilles roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT marlinsandrine roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT amselemserge roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy
AT lecronjeanclaude roleofil1binnlrp12associatedautoinflammatorydisordersandresistancetoantiil1therapy